Eli Lilly agreed to buy Waltham-based gut-drug maker Morphic Holding Inc. for about $3.2 billion, plowing some of the proceeds from obesity blockbuster Zepbound into its experimental pipeline.

S hares of Morphic Holding, Inc. (MORF) have gained 6.8% over the past four weeks to close the last trading session at $22.73, but there could still be a solid upside left in the stock if short ...

Revenue in Q3 2024 increased 20%, driven by volume growth from Mounjaro and Zepbound, partially offset by $1.42 billion of ...

The American pharmaceutical company Eli Lilly & Co. has entered into an agreement to acquire the biopharmaceutical company Morphic Holding Inc. This is reported in a press release Eli Lilly. The ...

Skyrocketing demand for weight loss and diabetes drugs has forced Eli Lilly and Novo Nordisk, to invest billions to increase ...

Currently, financial markets are experiencing a mix of optimism and caution as investors react to changing economic ...

Morphic Ethical Equities Fund Ltd. (AU:MEC) has released an update. Morphic Ethical Equities Fund Ltd. has announced a daily update on its ongoing buy-back program, with 30,232 ordinary fully paid ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We circle back on Schrödinger, Inc. for the first time since the second quarter of 2023 as the stock is now trading near 52-week lows. Schrödinger has two distinct businesses, a good chunk of ...

Based on the one-year price targets offered by 10 analysts, the average target price for JELD-WEN Holding Inc (NYSE:JELD) is $16 with a high estimate of $21 and a low estimate of $12. The average ...

The Q3 2024 charges were primarily related to the acquisition of Morphic Holding, Inc. The Q3 2023 charges were primarily related to the acquisitions of DICE Therapeutics, Inc., Versanis Bio ...

JELD-WEN Holding Inc (NYSE:JELD) is set to release its Q3 2024 earnings on Nov 5, 2024. The consensus estimate for Q3 2024 revenue is $990.75 million, and the earnings are expected to come in at $0.39 ...